Agile Therapeutics Q4 2023 Earnings Preview

seekingalpha03-28

Agile Therapeutics (OTC:AGRX) is scheduled to announce Q4 earnings results on Thursday, March 28th, before market open. The consensus EPS Estimate is -$0.92 and the consensus Revenue Estimate is $4.07...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2422486499?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-28 00:31","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2422486499","market":"nz","top_or_hot":-1,"title":"Agile Therapeutics Q4 2023 Earnings Preview","media":"seekingalpha","content":"<div>\n<p>Agile Therapeutics (OTC:AGRX) is scheduled to announce Q4 earnings results on Thursday, March 28th, before market open. The consensus EPS Estimate is -$0.92 and the consensus Revenue Estimate is $4.07...</p>\n\n<a href=\"https://seekingalpha.com/news/4084508-agile-therapeutics-q4-2023-earnings-preview\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Agile Therapeutics Q4 2023 Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAgile Therapeutics Q4 2023 Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-28 00:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4084508-agile-therapeutics-q4-2023-earnings-preview><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Agile Therapeutics (OTC:AGRX) is scheduled to announce Q4 earnings results on Thursday, March 28th, before market open. The consensus EPS Estimate is -$0.92 and the consensus Revenue Estimate is $4.07...</p>\n\n<a href=\"https://seekingalpha.com/news/4084508-agile-therapeutics-q4-2023-earnings-preview\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/4084508-agile-therapeutics-q4-2023-earnings-preview","article_id":"2422486499","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422486499","pubTimestamp":1711557083,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Agile Therapeutics  is scheduled to announce Q4 earnings results on Thursday, March 28th, before market open. The consensus EPS Estimate is -$0.92 and the consensus Revenue Estimate is $4.07M . Over the last 1 year, AGRX has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.  Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.   More on Agile Therapeutics  Agile Therapeutics announces delisting from Nasdaq Agile Therapeutics stock soars on complete debt payoff Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeutics Financial information for Agile Therapeutics","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"雅居乐治疗2023年第四季度盈利预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGRX":1},"content_text":"Agile Therapeutics (OTC:AGRX) is scheduled to announce Q4 earnings results on Thursday, March 28th, before market open. The consensus EPS Estimate is -$0.92 and the consensus Revenue Estimate is $4.07M (+1.8% Y/Y). Over the last 1 year, AGRX has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.  Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.   More on Agile Therapeutics  Agile Therapeutics announces delisting from Nasdaq Agile Therapeutics stock soars on complete debt payoff Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeutics Financial information for Agile Therapeutics","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422486499"}